Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 11 09 2019
accepted: 19 12 2019
revised: 16 11 2019
pubmed: 14 2 2020
medline: 15 12 2020
entrez: 14 2 2020
Statut: ppublish

Résumé

To evaluate the agreement among readers with different expertise in detecting suspicious lesions at prostate multiparametric MRI using Prostate Imaging Reporting and Data System (PI-RADS) version 2.1. We evaluated 200 consecutive biopsy-naïve or previously negative biopsy men who underwent MRI for clinically suspected prostate cancer (PCa) between May and September 2017. Of them, 132 patients underwent prostate biopsy. Seven radiologists (four dedicated uro-radiologists and three non-dedicated abdominal radiologists) reviewed and scored all MRI examinations according to PI-RADS v2.1. Agreement on index lesion detection was evaluated with Conger's k coefficient, agreement coefficient 1 (AC1), percentage of agreement (PA), and indexes of specific positive and negative agreement. Clinical and radiological features that may influence variability were evaluated. Agreement in index lesion detection among all readers was substantial (AC1 0.738; 95% CI 0.695-0.782); dedicated radiologists showed higher agreement compared with non-dedicated readers. Clinical and radiological parameters that positively influenced agreement were PSA density ≥ 0.15 ng/mL/cc, pre-MRI high risk for PCa, positivity threshold of PI-RADS score 4 + 5, PZ lesions, homogeneous signal intensity of the PZ, and subjectively easy interpretation of MRI. Positive specific agreement was significantly higher among dedicated readers, up to 93.4% (95% CI 90.7-95.4) in patients harboring csPCa. Agreement on absence of lesions was excellent for both dedicated and non-dedicated readers (respectively 85.1% [95% CI 78.4-92.3] and 82.0% [95% CI 77.2-90.1]). Agreement on index lesion detection among radiologists of various experiences is substantial to excellent using PI-RADS v2.1. Concordance on absence of lesions is excellent across readers' experience. • Agreement on index lesion detection among radiologists of various experiences is substantial to excellent using PI-RADS v2.1. • Concordance between experienced readers is higher than between less-experienced readers. • Concordance on absence of lesions is excellent across readers' experience.

Identifiants

pubmed: 32052171
doi: 10.1007/s00330-019-06654-2
pii: 10.1007/s00330-019-06654-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3383-3392

Références

Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767–1777. https://doi.org/10.1056/NEJMoa1801993
doi: 10.1056/NEJMoa1801993 pubmed: 29552975
Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. https://doi.org/10.1016/S0140-6736(16)32401-1
doi: 10.1016/S0140-6736(16)32401-1
Mottet N, van den Bergh RCN, Briers E et al (2019) Guidelines on prostate cancer 2019. Eur Assoc Urol. Available via https://uroweb.org/guideline/prostate-cancer/
Drost FJH, Osses DF, Nieboer D et al (2019) Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012663.pub2
Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol. https://doi.org/10.1007/s00330-011-2377-y
doi: 10.1007/s00330-011-2377-y
Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS Prostate Imaging - Reporting and Data System: 2015, version 2. Eur Urol. https://doi.org/10.1016/j.eururo.2015.08.052
doi: 10.1016/j.eururo.2015.08.052
Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System version 2. Eur Urol. https://doi.org/10.1016/j.eururo.2019.02.033
doi: 10.1016/j.eururo.2019.02.033
Rosenkrantz AB, Ginocchio LA, Cornfeld D et al (2016) Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists. Radiology. https://doi.org/10.1148/radiol.2016152542
doi: 10.1148/radiol.2016152542
Schimmöller L, Quentin M, Arsov C et al (2013) Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol. https://doi.org/10.1007/s00330-013-2922-y
doi: 10.1007/s00330-013-2922-y
Muller BG, Shih JH, Sankineni S et al (2015) Prostate cancer: interobserver agreement and accuracy with the revised Prostate Imaging Reporting and Data System at multiparametric MR imaging. Radiology. https://doi.org/10.1148/radiol.2015142818
doi: 10.1148/radiol.2015142818
Sonn GA, Fan RE, Ghanouni P et al (2018) Prostate magnetic resonance imaging interpretation varies substantially across radiologists. Eur Urol Focus. https://doi.org/10.1016/j.euf.2017.11.010
doi: 10.1016/j.euf.2017.11.010
Pickersgill NA, Vetter JM, Andriole GL et al (2018) Accuracy and variability of prostate multiparametric magnetic resonance imaging interpretation using the prostate imaging reporting and data system: a blinded comparison of radiologists. Eur Urol Focus. https://doi.org/10.1016/j.euf.2018.10.008
doi: 10.1016/j.euf.2018.10.008
Smith CP, Harmon SA, Barrett T et al (2019) Intra- and interreader reproducibility of PI-RADSv2: a multireader study. J Magn Reson Imaging. https://doi.org/10.1002/jmri.26555
doi: 10.1002/jmri.26555
Girometti R, Giannarini G, Greco F et al (2019) Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: a study using whole-mount histology as the standard of reference. J Magn Reson Imaging 49:546–555. https://doi.org/10.1002/jmri.26220
doi: 10.1002/jmri.26220 pubmed: 30187600
Feinstein AR, Cicchetti DV (1990) High agreement but low kappa: I. the problems of two paradoxes. J Clin Epidemiol. https://doi.org/10.1016/0895-4356(90)90158-L
doi: 10.1016/0895-4356(90)90158-L
Cicchetti DV, Feinstein AR (1990) High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol. https://doi.org/10.1016/0895-4356(90)90159-M
doi: 10.1016/0895-4356(90)90159-M
Shih JH, Greer MD, Turkbey B (2018) The problems with the kappa statistic as a metric of interobserver agreement on lesion detection using a third-reader approach when locations are not prespecified. Acad Radiol. https://doi.org/10.1016/j.acra.2018.01.030
doi: 10.1016/j.acra.2018.01.030
Hötker AM, Dappa E, Mazaheri Y et al (2019) The influence of background signal intensity changes on cancer detection in prostate MRI. Am J Roentgenol 212:823–829. https://doi.org/10.2214/AJR.18.20295
doi: 10.2214/AJR.18.20295
Stabile A, Dell’Oglio P, De Cobelli F et al (2018) Association between Prostate Imaging Reporting and Data System (PI-RADS) score for the index lesion and multifocal, clinically significant prostate cancer. Eur Urol Oncol 1:29–36. https://doi.org/10.1016/j.euo.2018.01.002
doi: 10.1016/j.euo.2018.01.002 pubmed: 31100225
Dell’Oglio P, Stabile A, Soligo M et al (2019) There is no way to avoid systematic prostate biopsies in addition to multiparametric magnetic resonance imaging targeted biopsies. Eur Urol Oncol 3:112–118. https://doi.org/10.1016/j.euo.2019.03.002
doi: 10.1016/j.euo.2019.03.002
Conger AJ (1980) Integration and generalization of kappas for multiple raters. Psychol Bull. https://doi.org/10.1037/0033-2909.88.2.322
doi: 10.1037/0033-2909.88.2.322
Gwet KL (2008) Computing inter-rater reliability and its variance in the presence of high agreement. Br J Math Stat Psychol 61:29–48. https://doi.org/10.1348/000711006X126600
doi: 10.1348/000711006X126600 pubmed: 18482474
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics. https://doi.org/10.2307/2529310
doi: 10.2307/2529310
Rais-Bahrami S, Siddiqui MM, Vourganti S et al (2015) Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. BJU Int 115:381–388. https://doi.org/10.1111/bju.12639
doi: 10.1111/bju.12639 pubmed: 24447678
Roobol MJ, Verbeek JFM, van der Kwast T, Kümmerlin IP, Kweldam CF, van Leenders GJLH (2017) Improving the Rotterdam European randomized study of screening for prostate cancer risk calculator for initial prostate biopsy by incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth. Eur Urol. https://doi.org/10.1016/j.eururo.2017.01.033
doi: 10.1016/j.eururo.2017.01.033
Greer MD, Brown AM, Shih JH et al (2017) Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: a multireader study. J Magn Reson Imaging 45:579–585. https://doi.org/10.1002/jmri.25372
doi: 10.1002/jmri.25372 pubmed: 27391860
Greer MD, Shih JH, Lay N et al (2019) Interreader variability of prostate imaging reporting and data system version 2 in detecting and assessing prostate cancer lesions at prostate MRI. AJR Am J Roentgenol 212:1197–1205. https://doi.org/10.2214/AJR.18.20536
doi: 10.2214/AJR.18.20536
Rouvière O, Puech P, Renard-Penna R et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100–109. https://doi.org/10.1016/S1470-2045(18)30569-2
doi: 10.1016/S1470-2045(18)30569-2 pubmed: 30470502
Luzzago S, Petralia G, Musi G et al (2019) Multiparametric magnetic resonance imaging second opinion may reduce the number of unnecessary prostate biopsies: time to improve radiologists’ training program? Clin Genitourin Cancer 17:88–96. https://doi.org/10.1016/j.clgc.2018.10.006
doi: 10.1016/j.clgc.2018.10.006 pubmed: 30527286

Auteurs

Giorgio Brembilla (G)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy. brembilla.giorgio@hsr.it.

Paolo Dell'Oglio (P)

Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Armando Stabile (A)

Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Anna Damascelli (A)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Lisa Brunetti (L)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Silvia Ravelli (S)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Giulia Cristel (G)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Elena Schiani (E)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Elena Venturini (E)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Daniele Grippaldi (D)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Vincenzo Mendola (V)

Vita-Salute San Raffaele University, Milan, Italy.

Paola Maria Vittoria Rancoita (PMV)

University Centre for Statistics in the Biomedical Sciences (CUSSB), Vita-Salute San Raffaele University, Milan, Italy.

Antonio Esposito (A)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Alberto Briganti (A)

Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Francesco Montorsi (F)

Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Alessandro Del Maschio (A)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Francesco De Cobelli (F)

Department of Radiology, Centre for Experimental Imaging, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH